Nuo Therapeutics, Inc.
AURX · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $97 | $70 | $56 | $66 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $97 | $70 | $56 | $65 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 47.4% | 44.6% | 22.7% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 60.6% | 77.2% | 75% | 78.1% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -48.1% | -87.3% | -153.8% | -152.2% |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | -52.1% | -92.8% | -154% | -125.8% |
| EPS Diluted | -0.01 | -0.014 | -0.016 | -0.011 |
| % Growth | 28.1% | 12.6% | -50% | – |
| Operating Cash Flow | -$1 | $0 | $0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$1 | $0 | -$0 | -$0 |